Phase 3 trial results show enlicitide, a once-daily oral PCSK9 inhibitor, cut LDL cholesterol by about 60% in high-risk ...

In this interview, Technology Networks spoke to Dr. Funda Meric-Bernstam about the landscape of personalized cancer therapy.

In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of ...

Interview insights explain how GLP-1R agonists access brain regions governing reward, motivation, and stress. Animal studies ...

Researchers found that cumulative exposure to disadvantaged neighborhoods predicted faster epigenetic aging across three ...

Analysis of US diet and health data shows adults consuming the most ultra-processed foods face a 47% higher risk of heart ...

Researchers have mapped lung cancer "neighborhoods", finding that cell metabolism is key for determining immunotherapy ...

A large genetic analysis identified 66 high-confidence genes linked to anxiety disorders across major brain regions. Findings ...

Scholars warn that replacing animal testing too quickly may threaten drug safety. As the FDA promotes AI and organoids, ...

Researchers have developed a device that cuts protein sample consumption by as much as 97% while still producing high-quality ...

Researchers found that individuals have distinct baseline levels of brain-derived proteins in cerebrospinal fluid, masking ...

Discover how researchers uncovered evidence of annual and centennial climate oscillations occuring during the "Snowball Earth ...